Advisors Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-579
Closed -$39K 1518
2022
Q2
$39K Sell
579
-1,002
-63% -$67.5K ﹤0.01% 1401
2022
Q1
$130K Sell
1,581
-1,445
-48% -$119K ﹤0.01% 1316
2021
Q4
$444K Sell
3,026
-122
-4% -$17.9K 0.01% 1038
2021
Q3
$557K Sell
3,148
-11
-0.3% -$1.95K 0.01% 972
2021
Q2
$510K Buy
3,159
+1,220
+63% +$197K 0.01% 995
2021
Q1
$332K Buy
1,939
+1,269
+189% +$217K 0.01% 1115
2020
Q4
$147K Buy
+670
New +$147K ﹤0.01% 1298